An overly conservative Bayesian analysis shows beyond a reasonable doubt that SARS-CoV-2 is laboratory derived. There’s a 99.8% probability SARS-CoV-2 came from a laboratory and only a 0.2% likelihood it came from nature
Antibody testing is critical for determining COVID vaccine efficacy and necessity, but FDA continues to recommend against the testing for anyone, including people who already had COVID and those who have been vaccinated against the virus.
Pfizer hiked its projections for COVID vaccine revenues, telling investors this week it expects booster shots, a vaccine targeting the Delta variant and anticipated authorization of its vaccines for children as young as 6 months will drive revenues higher.
